CASE STUDY PRA Successfully Rescues Phase II Hematology Study Effective Project Plan Identifies Risks, Enables Timely TransitionPRA Successfully Rescues Phase II Hematology Study Effective Project Plan Identifies Risks, Enables Timely Transition Primary Endpoint Time-to-response PRA Services Full service Indication Thrombocytopenia Drug Class Antibody Study Phase II Regions North America Western Europe Central Europe Eastern Europe Middle East Asia Pacific STUDY DESCRIPTION A Phase II, single-blind, randomized, placebo-controlled trial to study the efficacy and safety of Study Drug administered as adjunctive treatment to patients with acquired thrombotic thrombocytopenic purpura PRA was selected to take over a Phase II hematology study from another CRO. The project had mi

Join for free to read